Noncanonical NF-κB pathway driven inflammation across multiple cellular compartments identifies NIK as a therapeutic target for inflammatory bowel disease
-
By
-
Hao Xu
-
Dun Li
-
Jie Liang
-
Nathan Adamson
-
Alexis Scherl
-
Luli Zou
-
Crystal Hu
-
Elaine E. Storm
-
Christian B. Cox
-
Adam Johnson
-
Mary E. Keir
-
Hua Zhang
-
Saiyu Hang
-
June 9, 2026
-
0 min